This is an interview with Uri Lee, CEO of Xcell Therapeutics. Xcell is an international leader in serum-free, chemically defined media. Founded in 2015 and headquartered in Seoul, South Korea, the company developed CellCor™ CD MSC, the world’s first GMP-manufactured chemically defined cell culture media for mesenchymal stem cells (MSCs), and now works with 16 international distributors across Europe, North America, and beyond.
In this interview, we discuss the mission and purpose of Xcell Therapeutics, its product development pipeline, its rapid growth, and the company’s future goals. Along the way, Uri Lee also shares his views on exosome research, the emerging cultured meat market, and the types of partnerships Xcell is looking to build. Enjoy.




